AstraZeneca ovarian cancer drug slows disease markedly in study - Normangee Star

Normangee Star

AstraZeneca ovarian cancer drug slows disease markedly in study Normangee Star The trial established that the drug had significantly improved the progression-free survival (PFS) in ovarian cancer patients with germline BRCA-mutations (gBRCA) whose disease had relapsed, and had also failed to respond to platinum-based chemotherapy ... Why I chose to document my preventive double mastectomy on social mediaABC News all 4 news articles »

from Health - Google News http://ift.tt/2opKIW7